Please assess the completion status of the following clinical trial:

Trial Title: Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Requires rapid sequence intubation~* Succinylcholine is chosen paralytic agent~* IV or IO access has been established for rapid sequence intubation~* For IV access patients, their rapid sequence intubation case is the next occurring IV rapid sequence intubation case following an enrolled IO RSI case.~Exclusion Criteria:~* Vascular access other than IV or IO has been established

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intravenous (IV) drug delivery (Type: None): patients on whom intravenous vascular access has been established for the purpose of rapid sequence intubation drug delivery.
- Intraosseous (IO) drug delivery (Type: None): Patients on whom intraosseous vascular access has been established for rapid sequence intubation drug delivery.

Based on this trial design, predict the completion outcome and termination type (if applicable).